Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up

Mayo Clinic

Status

Completed

Conditions

Prostate Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01098552

Mayo Clinic Prostate SPORE

1937-00

Details and patient eligibility

About

This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer.

This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other markers. Also environmental and genetic factors that might be responsible for prostate cancer are being investigated.

Enrollment

4,900 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Informed consent explained and signed prior to any study related procedures.
Age ≥18 years
Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better, or Karnofsky performance of 60% or better.
Histologically confirmed adenocarcinoma of the prostate within 10 years of study entry.
Willingness to return to Mayo Clinic Rochester for follow-up or participate in mail-in PSA processing.
Must be disease-free from a previous diagnosis of cancer for a period of time = 5 years excluding cutaneous malignancies of squamous cell or basal cell carcinoma.

Exclusion criteria

Life expectancy < 5 years.
Inability to return to Mayo Rochester for follow-up appointments, sera, and urine collection per protocol.
Previous or a concurrent diagnosis of cancers other than basal cell or invasive squamous cell carcinoma of skin within the past 5 years.